(Translation) February 27, 2019 Ref: SET-2019-003 Re: Management's Discussion and Analysis and operating results for the Year 2018 Attn. to: President The Stock Exchange of Thailand Filter Vision

disseminated to many media channels that THG would sign the contract to import mRNA COVID-19 vaccines (Pfizer) and the first 5 million doses of the vaccine would be delivered by July 2021 which does not happen

calculation 53,000,000 MYR in maximum. This transaction is categorized as the asset’s acquisi Announcement TorJor20/2551 about the regulation on sign disposition of assets, effective on August 31, 2008 and

(Translation) th August, Ref: SET-- Re: Management's Discussion and Analysis and Operating Results for Quarter / Dear: The President The Stock Exchange of Thailand Filter Vision Public Company

Board of Directors has the opionions that this transaction is reasonable to company’s business operation and it is the most beneficial to the company and its shareholders. As to considering the operating

languages, the Thai version shall prevail. The objective of this MD&A is to present the information and the explanation of financial status and operating results as of the date hereof. However, the

jointly sign and seal of the Company. Mr.Chirasak Chiyachantana Mrs.Sangsri Chiyachantana Ms. Jatechanya Boonchaleo Two of these tree directors jointly sign and seal of the company. World Industrial Estate

Chiyachantana Mr.Chiraphol Chiyachantana Ms.Kusuma Palaprom Two of these four directors jointly sign and seal of the Company. Mr.Chirasak Chiyachantana Mrs.Sangsri Chiyachantana Ms. Jatechanya Boonchaleo Two of

operating result (%) Y2019 Y2018 %YoY Gross profit margin (%) 43.44% 40.90% 2.54% Selling expenses and administrative expenses to total revenue (%) 44.67% 40.49% 4.18% Net profit margin (%) 0.83% 2.64% -1.81

the first quarter of 2019 from THB 5.2 billion for the first quarter 2018. Sales Revenue in USD terms decreased 1% to USD 162m for Q1 2019 from USD 165m in Q1 2018. Operating Profits decreased 52% to